ArticleRadiology case reports2025
A rare case of mediastinal liposarcoma: Multidisciplinary approach and clinical challenges.
Article in Radiology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mediastinal liposarcomas are rare, aggressive tumors that represent a small proportion of mediastinal masses and present significant diagnostic and therapeutic challenges due to their proximity to vital structures. This case report details a 58-year-old female who presented with progressive dyspnea and chest pain, initially attributed to more common causes. However, further investigation, including thoracic CT scan, revealed a 15 cm anterior mediastinal mass with pericardial effusion. Biopsy and histopathological examination confirmed the diagnosis of dedifferentiated liposarcoma (DDL). Given the tumor's large size and proximity to critical structures, surgical resection was initially deemed unresectable, and the patient was started on neoadjuvant chemotherapy (EIM regimen). However, despite tumor progression after chemotherapy, the patient underwent successful surgical resection with narrow margins. Postsurgery, the patient received adjuvant radiotherapy to reduce the risk of local recurrence. Despite mild side effects such as acute esophagitis during radiotherapy, the patient showed no signs of disease recurrence at the 12-month follow-up. This case highlights the challenges in diagnosing and managing mediastinal liposarcomas and demonstrates a multimodal treatment approach, including chemotherapy, surgery, and radiotherapy, which can lead to favorable short-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.